NCT04212624View on ClinicalTrials.gov

Clinical Research of Human Retinal Pigment Epithelial (HuRPE) Cell Injection on Atrophy of High Myopia Macular Area

NAUnknownINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Degenerative Myopia With Macular Hole
Interventions
OTHER

Human retinal pigment epithelial (HuRPE) cell injection

Human retinal pigment epithelial cell injection Dosage form and specifications: injection; 600,000 cells / branch (200μl), 1 million cells / branch (200μl), 2 million cells / branch (200μl) Transportation and storage: sealed, stored at 2-8 ° C, valid for 6 hours

Sponsors

Collaborators (1)

Eyecure Therapeutics Inc.
All Listed Sponsors
collaborator

Eyecure Therapeutics Inc.

INDUSTRY

lead

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER